Drugs

, Volume 52, Supplement 7, pp 1–7 | Cite as

Unresolved Issues in the Prevention of Venous Thromboembolism

  • Trevor Baglin
Article
  • 7 Downloads

Summary

Venous thromboembolism is a potentially fatal complication of surgery. The use of graded pressure stockings in combination with unfractionated heparin (UFH) or a low molecular weight heparin (LMWH) appears to be the safest and most effective method of prevention. With some LMWHs, the risk of venous thromboembolism appears to be lower than that associated with the use of standard UFH.

A comparison of heparin given before versus after surgery (with all patients receiving graded pressure stockings) is justified. More information on the benefit-risk ratio of minidose warfarin is also required.

The risk of pulmonary embolism (PE) following discharge from hospital after general surgery is relatively low and the extended use of heparin may not be justified. The value of graded pressure stockings and minidose warfarin for the prevention of PE should be determined. The risk of late PE after orthopaedic surgery is unknown and also needs to be determined.

Keywords

Pulmonary Embolism Enoxaparin Unfractionated Heparin Pharmacological Prophylaxis Ancrod 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    International Multicentre Trial. Reappraisal of results of International Multicentre Trial. Lancet 1977; I: 567–9Google Scholar
  2. 2.
    Sagar S, Massey J, Sanderson J. Low-dose heparin prophylaxis against fatal pulmonary embolism. BMJ 1975; 4: 257–9PubMedCrossRefGoogle Scholar
  3. 3.
    Bergqvist D, Lindblat B. A 30 year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 1985; 72: 105–8PubMedCrossRefGoogle Scholar
  4. 4.
    Ruckley C, Thurston C. Pulmonary embolism in surgical patients: 1959–79. BMJ 1982; 284: 1100–2PubMedCrossRefGoogle Scholar
  5. 5.
    Haake D, Berkman S. Venous thromboembolic disease after hip surgery. Clin Orthop 1989; 242: 212–31PubMedGoogle Scholar
  6. 6.
    Collins R, Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162–73PubMedCrossRefGoogle Scholar
  7. 7.
    Gallus A. Anticoagulants in the prevention of venous thrombo-embolism. In: Hirsh J, editor. Ballières Clinical Haematology. London: Ballière Tindall, 1990; 3: 651–84Google Scholar
  8. 8.
    Nurmohamed M, Rosendaal F, Buller H, et al. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340: 152–6PubMedCrossRefGoogle Scholar
  9. 9.
    Leizorovicz A, Haugh M, Chapulis F, et al. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305: 913–20PubMedCrossRefGoogle Scholar
  10. 10.
    Colwell C, Spiro T, Trowbridge A, et al. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. J Bone Joint Surg Am 1994; 76: 3–14PubMedGoogle Scholar
  11. 11.
    Dale C, Gallus A, Wycherley A, at al. Prevention of venous thrombosis by minidose warfarin after joint replacement. BMJ 1991; 303; 224PubMedCrossRefGoogle Scholar
  12. 12.
    Fordyce M, Baker A, Staddon G. Efficacy of fixed minidose warfarin prophylaxis in total hip replacement. BMJ 1991; 303: 219–20PubMedCrossRefGoogle Scholar
  13. 13.
    Poller L, McKernan A, Thomson J, et al. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. BMJ 1987; 295: 1309–12PubMedCrossRefGoogle Scholar
  14. 14.
    Antiplatelet Trialist’s Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308: 235–46CrossRefGoogle Scholar
  15. 15.
    Scurr J, Ibrahim S, Faber R, et al. The efficacy of graduated pressure stockings in the prevention of deep venous thrombosis. Br J Surg 1977; 64: 371–3PubMedCrossRefGoogle Scholar
  16. 16.
    Torngren S. Low dose heparin and compression stockings in the prevention of postoperative deep venous thrombosis. Br J Surg 1980; 67: 482–4PubMedCrossRefGoogle Scholar
  17. 17.
    Wille-Jorgensen P, Thorup J, Fischer A, et al. Heparin with and without graded compression stockings in the prevention of thromboembolic complications of major abdominal surgery: a randomised trial. Br J Surg 1985; 72: 579–81PubMedCrossRefGoogle Scholar
  18. 18.
    Gatterer R. Risk/benefit of heparin-dihydroergotamine thromboembolic prophylaxis. Lancet 1986; II: 638CrossRefGoogle Scholar
  19. 19.
    Schlag G, Poigenfurst J, Gaudernak T. Risk/benefit of heparin-dihydroergotamine thromboembolic prophylaxis. Lancet 1986; II: 1465CrossRefGoogle Scholar
  20. 20.
    Laverick M, Croal S, Mollan R. Orthopaedic surgeons and thromboprophylaxis. BMJ 1991; 303: 549–50PubMedCrossRefGoogle Scholar
  21. 21.
    Kearon C, Hirsh J. Starting prophylaxis for venous thromboem-bolism postoperatively. Arch Intern Med 1995; 155: 366–72PubMedCrossRefGoogle Scholar
  22. 22.
    Hull R, Raskob G, Gent M, et al. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA 1990; 263: 2313–7PubMedCrossRefGoogle Scholar
  23. 23.
    Leclerc J, Geerts W, Desjardins L, et al. Prevention of deep vein thrombosis after major knee surgery: a randomised, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost 1992; 67: 417–23PubMedGoogle Scholar
  24. 24.
    Turpie A, Levine M, Hirsh J, et al. A randomised controlled trial of a low molecular weight heparin (enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315: 925–9PubMedCrossRefGoogle Scholar
  25. 25.
    Levine M, Hirsh J, Gent M. Prevention of deep vein thrombosis after elective hip surgery: a randomised trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 1991; 114: 545–51PubMedGoogle Scholar
  26. 26.
    Caprini J, Arcelus J, Hoffman K, et al. Prevention of venous thromboembolism in North America: results of a survey among general surgeons. J Vasc Surg 1994; 20: 751–8PubMedCrossRefGoogle Scholar
  27. 27.
    Scurr J, Coleridge-Smith P, Hasty J. Deep venous thrombosis: a continuing problem. BMJ 1988; 297: 28PubMedCrossRefGoogle Scholar
  28. 28.
    Huber O, Bounameaux H, Borst F, et al. Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 1992; 127: 310–3PubMedCrossRefGoogle Scholar
  29. 29.
    Kakkar V, Cohen A, Edmonson R, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341: 259–65PubMedCrossRefGoogle Scholar
  30. 30.
    Kakkar V, Cohen A, Edmonson R, et al. Prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341: 824CrossRefGoogle Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • Trevor Baglin
    • 1
  1. 1.Department of Haematology, Diagnostic and Clinical Support ServicesAddenbrooke’s NHS TrustCambridgeEngland

Personalised recommendations